Skip to content

Ardent 医疗

US · ARDT #2983 按市值排名 上市于 2024
11.95 -0.25 -2.05%
实时 - 追踪5344个代码 - 心跳于4秒前 · 2026-10-16 19:30

✦ 量化股权信号 计算方式说明

增持
  • 最近一期（2026/Q3）披露持股的机构数量减少了3家。
  • 机构持股总比例上升了0.6个百分点。

机构持股

机构持股比例
98.46% +0.57pp
机构数量
168 -3
数据截至
2026/Q3 较上一报告期

持股变动 vs 资金流向

方向分歧

机构在上一报告期增持了股份，同时该股在最近20个交易日的主力资金呈净流出——两者方向出现分歧。

机构持股变动数据按季度发布且存在滞后；资金流向数据为每日更新。请将其作为方向性的交叉验证参考，而非精确的择时信号。

持股人类型

VC/PE Fund54.77%
Public Company22.35%
Mutual Fund10.01%
REIT6.62%
Hedge Fund4.03%
Individual/Insider1.72%
Private Company0.42%
Government Pension Fund0.24%

主要股东 截至 2026-06-30

Equity Group Investments 54.77% · 77.25M 股
Pure Health Holding PJSC 21.46% · 30.26M 股
Ventas, Inc. 6.62% · 9.34M 股
BlackRock 1.54% · 2.18M 股
Columbia Management Investment Advisers, LLC 1.50% · 2.11M 股
GoldenTree Asset Management LP 1.12% · 1.58M 股
AQR Capital Management 1.02% · 1.44M 股
Bridgeway Capital Management, LLC 0.99% · 1.39M 股
Vanguard Capital Management, LLC 0.80% · 1.12M 股
Castleknight Management LP 0.76% · 1.08M 股

条形长度是相对于此处列出的最大股东而言，并非相对于公司100%股权。

内部人持股

共追踪50份申报 · 32次买入 · 18次卖出

姓名职务持股比例
Pure Health Holding PJSC -- 21.46%
Stephen Petrovich Executive VP, General Counsel, Chief Legal Officer & Secretary 0.75%
Martin Bonick Chief Executive Officer 0.39%
Alfred Lumsdaine Chief Financial Officer 0.11%
David Byers Chief Accounting Officer 0.07%
Peter C. Bynoe Director 0.07%
William Goodyear Director 0.07%
Ellen Havdala Director 0.07%
Robert Webb Director 0.04%
David Schultz President of Hospital Operations 0.03%

内部人交易 最近的 Form 4 申报记录

日期姓名职务类型股数价格
2026-09-24 Alfred Lumsdaine Chief Financial Officer Sale to Issuer -3,389 $10.54
2026-09-24 Stephen Petrovich Executive VP, General Counsel, Chief Legal Officer & Secretary Sale to Issuer -788 $10.54
2026-09-24 David Byers Chief Accounting Officer Sale to Issuer -524 $10.54
2026-08-26 Martin Bonick Chief Executive Officer Intent to Sell (Form 144) -35,930 $11.08
2026-08-24 Martin Bonick Chief Executive Officer Intent to Sell (Form 144) -35,930 $11.17
2026-08-19 Martin Bonick Chief Executive Officer Intent to Sell (Form 144) -35,930 $10.50
2026-08-17 Martin Bonick Chief Executive Officer Intent to Sell (Form 144) -35,930 $10.95
2026-06-30 David Caspers Chief Operating Officer Other Acquisition +103,653 --
2026-06-04 Alfred Lumsdaine Chief Financial Officer Open Market Acquisition +10,000 $8.81
2026-06-04 Robert DeMichiei Director Open Market Acquisition +11,260 $8.73
2026-03-31 Mark Sotir Chairperson Other Acquisition +14,231 --
2026-03-31 William Goodyear Director Other Acquisition +14,231 --
2026-03-31 Peter C. Bynoe Director Other Acquisition +14,231 --
2026-03-31 Robert Webb Director Other Acquisition +14,231 --
2026-03-31 Alfred Lumsdaine Chief Financial Officer Sale to Issuer -6,891 $8.56–8.67
2026-03-31 Alfred Lumsdaine Chief Financial Officer Other Acquisition +53,846 --
2026-03-31 Stephen Petrovich Executive VP, General Counsel, Chief Legal Officer & Secretary Sale to Issuer -3,233 $8.56–8.67
2026-03-31 Stephen Petrovich Executive VP, General Counsel, Chief Legal Officer & Secretary Other Acquisition +24,904 --
2026-03-31 Ellen Havdala Director Other Acquisition +14,231 --
2026-03-31 Robert DeMichiei Director Other Acquisition +14,231 --

Form 4 申报记录，每家公司显示最新的一批。"Other Derivative Acquisition"（其他衍生品获取）类目多为限制性股票/期权归属，并非公开市场买入——具体类型见"类型"列。

报价时间 2026-10-16 19:30:05 · 仅供参考，不构成投资建议，也未考虑您的具体情况。

Ardent 医疗 讨论区 0 条评论

发表评论